Skip to content

Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes

Improving Hypertension Control in Individuals With Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00743808
Enrollment
11510
Registered
2008-08-29
Start date
2006-12-31
Completion date
2010-09-30
Last updated
2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

hypertension, diabetes, quality improvement, blood pressure

Brief summary

Twelve health organizations from around the US were selected to participate in a chart review Hypertension and Diabetes Initiative with the goal of improving blood pressure control in persons with diabetes. Hypothesis: A three-phase quality improvement initiative facilitated and monitored through the International Diabetes Center (IDC) will result in improved population-mean systolic blood pressure in the aggregate data pool of patients from all 12 participating sites at geographically distinct health systems.

Detailed description

Phase 1 - Preparation: Each participating site begins to organize itself for the project. Baseline data will be collected and will be used to benchmark where each site is relative to blood pressure control/management of persons with diabetes prior to the implementation of the training programs. Phase 2 - Implementation: Sites begin to address the gaps they have identified that affect blood pressure outcomes of patients with diabetes. IDC provides two on-site training programs for providers and support staff. Phase 3 - Follow-up: IDC provides on-going support to each site via individual and collaborative conference calls and resources on the project Web site. Patient and visit data (audit form) will be collected six and 12 months after training. This data will be compared to the site's pre-training data.

Interventions

OTHERquality improvement

3-phase quality improvement intervention

Sponsors

Advocate Medical Group
CollaboratorOTHER
Baystate Health
CollaboratorOTHER
Corewell Health East
CollaboratorOTHER
Columbia Park Medical Group
CollaboratorOTHER
Humboldt Del Norte Independent Practice Association
CollaboratorUNKNOWN
Metropolitan Health
CollaboratorUNKNOWN
Park Nicollet Clinic
CollaboratorOTHER
PeaceHealth Medical Group
CollaboratorOTHER
Sanford Clinic
CollaboratorUNKNOWN
TriHealth Inc.
CollaboratorOTHER
University Hospitals Medical Practices
CollaboratorUNKNOWN
Warren Clinic
CollaboratorUNKNOWN
Novartis
CollaboratorINDUSTRY
HealthPartners Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* ICD-9 Code 250 (indicates type 1 or type 2 diabetes) * ICD- Code 648.0 (indicates pregnancy with type 1 or type 2 diabetes) * ICD-9 Code 357.2 or 362.0, indicating complications of diabetes. * A prescription for insulin or oral hypoglycemic agents * Include those 18-75 years

Exclusion criteria

* Attend a dialysis unit (if the nephrologist is primary care manager) * Have gestational diabetes (ICD-9 Code 648.8) * Have a terminal illness (e.g., hospice patient) * Do not have a documented blood pressure within the past year (this is asked on the audit form)

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure1 year

Secondary

MeasureTime frame
Measure changes in action taken related to improving blood pressure management as percent of providers reporting changing (initiating or adjusting) blood pressure medication1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026